INHIBITOR THERAPTICS INC (INTI) SEC filings
INTI SEC filings moved a median of -0.75% by the close. INTI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the INTI overview →
18 measured INTI SEC filing events.
Where these INTI SEC filings landedvs 12 measured INTI SEC filing reactions
| Middle 50% of INTI SEC filing reactions | -9.69% to +4.61% |
|---|---|
| Median reaction (to close) | -0.75% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 INTI SEC filing events with a measured close landed between -9.69% and +4.61%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Inhibitor Therapeutics, For: Sep 15 | SEC filing · Form 8-K | — | — | |
| Form DEF 14A Inhibitor Therapeutics, For: Aug 17 | SEC filing · Form DEF | +0.00% | -1.11% | |
| Form 10-Q Inhibitor Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.11% | |
| Form 10-Q Inhibitor Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Inhibitor Therapeutics, For: Apr 01 | SEC filing · Form 8-K | — | — | |
| Form 10-K Inhibitor Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -10.00% | -10.00% | |
| Form 8-K Inhibitor Therapeutics, For: Feb 24 | SEC filing · Form 8-K | +1.97% | +18.42% | |
| Form 10-Q Inhibitor Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Inhibitor Therapeutics, For: Oct 24 | SEC filing · Form 8-K | -0.40% | -0.40% | |
| Form 10-Q Inhibitor Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-Q Inhibitor Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +77.37% | |
| Form 10-K Inhibitor Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -9.58% | -9.58% | |
| Form 10-Q Inhibitor Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Inhibitor Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Inhibitor Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-K Inhibitor Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -12.10% | |
| Form 8-K Inhibitor Therapeutics, For: Dec 12 | SEC filing · Form 8-K | +13.11% | +24.59% | |
| Form 10-Q Inhibitor Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -41.35% | -41.35% |
Keep exploring
More INTI: earnings → · analyst actions → · INTI overview →